Login / Signup

Contemporary role of avelumab first-line maintenance in advanced urothelial carcinoma with consideration of the JAVELIN Bladder 100 comprehensive clinical subgroup analyses.

Kevin K ZarrabiBenjamin MironDaniel M Geynisman
Published in: Translational andrology and urology (2024)
Keyphrases
  • spinal cord injury
  • randomized controlled trial
  • phase iii
  • urinary tract
  • open label